About CEDARLANE Laboratories

Cedarlane Laboratories Limited is an ISO 9001 and ISO 13485 certified privately held Canadian corporation. Cedarlane has been in business since 1957. It was incorporated in 1975 by three Canadian researchers originating from the University of Toronto and Ontario Cancer Institute; Dr. S. Abrahams, Dr. A.J. Farmilo and R.C. Course. The company has evolved to become a leading supplier of research reagents in Canada and world-wide, particularly in the area of immunology. It is located in Burlington, Ontario, Canada with close proximity to Pearson International Airport and the Toronto area.

Cedarlane is both a manufacturer and distributor. Manufactured products include monoclonal antibodies, polyclonal antibodies, cell separation media, complement for tissue typing, and immunocolumns. These are available world-wide through a well-established network of international distributors. Products distributed within Canada are imported from over 500 international suppliers and are offered to our Canadian customer base of ~ 20,000 life science researchers. Cedarlane Shipping Supplies Inc. is a daughter company established ~ 5 years ago and specializes in providing shipping supplies for temperature-sensitive goods.

Facts about CEDARLANE Laboratories
  • Focus : Manufacturer
  • Industry : Biotechnology

Here you will find CEDARLANE Laboratories Ltd.

See the theme worlds for related content

Topic world Antibodies

Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous

View topic world

Topic world Antibodies

Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous